Abstract | OBJECTIVE:
Saikosaponin c (SSc), a compound purified from the traditional Chinese herb of Radix Bupleuri was previously identified to exhibit anti-HBV replication activity. However, the mechanism through which SSc acts against HBV remains unknown. In this study, we investigated the mechanism of SSc mediated anti-HBV activity. METHODS: HepG2.2.15 cells were cultured at 37 ℃ in the presence of 1-40 μg/mL of SSc or DMSO as a control. The expression profile of HBV markers, cytokines, HNF1α and HNF4α were investigated by real-time quantitative PCR, Elisa, Western blot and Dot blotting. Knockdown of HNF1α or HNF4α in HepG2.2.15 cells was mediated by two small siRNAs specifically targeting HNF1α or HNF4α. RESULTS: We found that SSc stimulates IL-6 expression, leading to attenuated HNF1α and HNF4α expression, which further mediates suppression of HBV pgRNA synthesis. Knockdown of HNF1α or HNF4α in HepG2.2.15 cells by RNA interference abrogates SSc's anti-HBV role. Moreover, SSc is effective to both wild-type and drug-resistant HBV mutants. CONCLUSION: SSc inhibits pgRNA synthesis by targeting HNF1α and HNF4α. These results indicate that SSc acts as a promising compound for modulating pgRNA transcription in the therapeutic strategies against HBV infection.
|
Authors | Yanchao Pan, Zhiyi Ke, Hong Ye, Lina Sun, Xiaoyan Ding, Yun Shen, Runze Zhang, Jing Yuan |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 68
Issue 12
Pg. 1025-1034
(Dec 2019)
ISSN: 1420-908X [Electronic] Switzerland |
PMID | 31531682
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- HNF1A protein, human
- HNF4A protein, human
- Hepatitis B Surface Antigens
- Hepatitis B e Antigens
- Hepatocyte Nuclear Factor 1-alpha
- Hepatocyte Nuclear Factor 4
- RNA, Small Interfering
- RNA, Viral
- Saponins
- pgRNA
- RNA
- Oleanolic Acid
- saikosaponin D
|
Topics |
- Antiviral Agents
(pharmacology)
- Hep G2 Cells
- Hepatitis B Surface Antigens
(metabolism)
- Hepatitis B e Antigens
(metabolism)
- Hepatitis B virus
(drug effects, genetics, immunology, metabolism)
- Hepatocyte Nuclear Factor 1-alpha
(genetics, metabolism)
- Hepatocyte Nuclear Factor 4
(genetics, metabolism)
- Humans
- Oleanolic Acid
(analogs & derivatives, pharmacology)
- RNA
(biosynthesis)
- RNA Interference
- RNA, Small Interfering
(genetics)
- RNA, Viral
(biosynthesis)
- Saponins
(pharmacology)
|